Serina Therapeutics News

Serina Therapeutics | 8-K: Current report

16:19 ET

Serina Therapeutics | 8-K: Current report

Dec 11 07:16 ET

Serina Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Juvenescence Limited(42.0%),JuvVentures (UK) Limited(41.3%)

Dec 9 16:52 ET

Serina Therapeutics | 8-K: Current report

Dec 2 17:20 ET

Serina Therapeutics | 424B3: Prospectus

Nov 22 16:22 ET

Serina Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Broadwood Partners, L.P.(2.1%),Broadwood Capital, Inc.(2.1%), etc.

Nov 14 17:13 ET

Serina Therapeutics | 8-K: Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Nov 12 17:11 ET

Serina Therapeutics | 10-Q: Quarterly report

Nov 12 16:11 ET

Serina Therapeutics | ARS: Annual Report to Security Holders

Nov 6 16:48 ET

Serina Therapeutics | DEFA14A: Others

Nov 6 16:39 ET

Serina Therapeutics | DEF 14A: Definitive information statements

Nov 6 06:37 ET

Serina Therapeutics | DEFC14A: Others

Oct 31 09:17 ET

Serina Therapeutics | 8-K: Current report

Oct 2 08:34 ET

Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory

Sep 24 16:32 ET

Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory

Sep 20 19:02 ET

Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MINTZ STEVEN

Sep 16 18:57 ET

Serina Therapeutics | 8-K: Current report

Sep 12 17:19 ET

Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEDGER STEVEN A

Sep 11 16:32 ET

Serina Therapeutics | 8-K: Current report

Sep 5 13:40 ET

Serina Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 23 17:26 ET